How the Development Bank of Wales supports tech-driven companies, ranging from start-ups to established businesses ...

Despite the above, there are still a couple of silver linings that provide more than enough reason to be bullish about this stock.

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...

Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ETCompany ParticipantsDavid Constable - Chairman & CEOJoe ...

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall ...

With the rise of exchange-traded funds, or ETFs, that let you buy and sell throughout the trading day, mutual funds have fallen out of the limelight. But don't write off the old stalwart of ...

Ladies and gentlemen, thank you for standing-by, and welcome to the Lilly Q3 2024 Earnings Call. [Operator Instructions] I ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q3 2024 earnings call. [Operator ...

We’re maintaining our fair value estimate of $580 per share for Eli Lilly LLY following the firm’s somewhat disappointing third-quarter results. We think most of the pressure on GLP-1 sales results ...

In her first earnings call as Alphabet CFO, Anat Ashkenazi said more streamlining will be needed so the company can invest in ...

Pierre S. Sayad, PhD, M.S., Appointed Chief Medical Officer ~~ Terry Evans Appointed Chief Commercial Officer ~~ Christiana Cioffi, MBA, ...